Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 2
Submit an article Journal homepage
2,452
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial

Allison R. ThompsonPfizer Vaccine Clinical Research & Development, Pearl River, NY, USACorrespondence[email protected]
View further author information
,
Nicola P. KleinKaiser Permanente Vaccine Study Center, Oakland, CA, USAView further author information
,
H. Jackson DowneyJacksonville Center for Clinical Research, Jacksonville, FL, USAView further author information
,
Scott PattersonPfizer Vaccine Clinical Research & Development, Collegeville, PA, USAView further author information
,
Vani SundaraiyerDepartment of Biostatistics, Syneos Health, Princeton, NJ, USAView further author information
,
Wendy WatsonPfizer Vaccine Clinical Research & Development, Collegeville, PA, USACorrespondence[email protected]
View further author information
,
Keri ClarkePfizer Vaccine Research & Development, Tadworth, Surrey, UKView further author information
,
Kathrin U. JansenPfizer Vaccine Clinical Research & Development, Pearl River, NY, USAView further author information
,
Shite SebastianPfizer Vaccine Clinical Research & Development, Pearl River, NY, USAView further author information
,
William C. GruberPfizer Vaccine Clinical Research & Development, Pearl River, NY, USAView further author information
,
Daniel A. ScottPfizer Vaccine Clinical Research & Development, Collegeville, PA, USAView further author information
&
Beate Schmöele-ThomaVaccines Research and Development, Pfizer Pharma GmbH, Berlin, GermanyORCID Iconhttp://orcid.org/0000-0003-4632-357XView further author information
ORCID Icon show all
Pages 444-451 | Received 11 Jun 2018, Accepted 01 Oct 2018, Published online: 25 Oct 2018

Related Research Data

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
Source: Elsevier BV
Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older
Source: Elsevier BV
Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine–naïve adults 60–64 years of age
Source: Elsevier BV
Assessment of functional antibacterial opsonophagocytic antibodies elicited by 13-valent pneumococcal conjugate vaccine administered concomitantly with trivalent influenza vaccine in a randomized clinical trial in adults aged ≥65 years.
Source: Elsevier BV

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.